Regenerated Ni-Doped LiCoO2 from Spent Lithium-Ion Batteries as a Stable Cathode at 4.5 V.

In the context of the increasing number of spent lithium-ion batteries, it is urgent to explore cathode regeneration and upcycling solutions to reduce environmental pollution, promote resource reuse, and meet the demand for high-energy cathode materials. Here, a closed-loop recycling method is introduced, which not only reclaims cobalt and lithium elements from spent lithium-ion batteries but also converts them into high-voltage LiCoO2 (LCO) materials. This approach involved pretreatment, chlorination roasting, water leaching, and ion doping to regenerate nickel-doped LCO (Ni-RLCO) materials. The doping of nickel effectively enhances the electrochemical stability of the LCO cathode at 4.5 V. The Ni-RLCO cathode exhibited a high discharge specific capacity of 185.28 mAh/g at a rate of 0.5 C with a capacity retention of 86.3% after 50 cycles and excellent rate capacity of 156.21 mAh/g at 2 C. This work offers a approach in significance for upcycling spent LCO into high-energy-density batteries with long-term cycling stability under high voltage.

Dose-response associations of triglyceride to high-density lipoprotein cholesterol ratio and triglyceride-glucose index with arterial stiffness risk.

BACKGROUND: The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio and triglyceride-glucose (TyG) index are novel indexes for insulin resistance (IR). We aimed to evaluate associations of TG/HDL-C and TyG with arterial stiffness risk. METHODS: We enrolled 1979 participants from the Rural Chinese Cohort Study, examining arterial stiffness by brachial-ankle pulse wave velocity (baPWV). Logistic and linear regression models were employed to calculate effect estimates. For meta-analysis, we searched relevant articles from PubMed, Embase and Web of Science up to August 26, 2023. The fixed-effects or random-effects models were used to calculate the pooled estimates. We evaluated dose-response associations using restricted cubic splines. RESULTS: For cross-sectional studies, the adjusted ORs (95%CIs) for arterial stiffness were 1.12 (1.01-1.23) and 1.78 (1.38-2.30) for per 1 unit increment in TG/HDL-C and TyG. In the meta-analysis, the pooled ORs (95% CIs) were 1.26 (1.14-1.39) and 1.57 (1.36-1.82) for per 1 unit increment of TG/HDL-C and TyG. Additionally, both TG/HDL-C and TyG were positively related to PWV, with ß of 0.09 (95% CI 0.04-0.14) and 0.57 (95% CI 0.35-0.78) m/s. We also found linear associations of TG/HDL-C and TyG with arterial stiffness risk. CONCLUSIONS: High TG/HDL-C and TyG were related to increased arterial stiffness risk, indicating TG/HDL-C and TyG may be convincing predictors of arterial stiffness.

Recycled Graphite from Spent Lithium-Ion Batteries as a Conductive Framework Directly Applied in Red Phosphorus-Based Anodes.

The recycling of spent graphite from waste lithium-ion batteries (LIBs) holds great importance in terms of environmental protection and conservation of natural resources. In this study, a simple two-step method involving heat treatment and solution washing was employed to recycle spent graphite. Subsequently, the recycled graphite was milled with red phosphorus to create a carbon/red phosphorus composite that served as an anode material for the new LIBs, aiming to address the low capacity issue. In a half-cell configuration, the carbon/red phosphorus composite exhibited remarkable cycling stability, maintaining a capacity of 721.7 mAh g-1 after 500 cycles at 0.2 A g-1, and demonstrated an excellent rate performance with a capacity of 276.2 mAh g-1 at 3 A g-1. The improved performance can be attributed to the structure of the composite, where the red phosphorus particles are covered by the carbon layer. This composite outperformed pure recycled graphite, highlighting its potential in enhancing the electrochemical properties of LIBs. Furthermore, when the carbon/red phosphorus composite was assembled into a full-cell configuration with LiCoO2 as the cathode material, it displayed a stable electrochemical performance, further validating its practical applicability. This work presents a promising and green strategy for recycling spent graphite and using it in the production of new batteries. The findings offer a high potential for commercialization, contributing to the advancement of sustainable and ecofriendly energy storage technologies.

Alcohol Consumption and Risk of Fractures: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.

Alcohol consumption remains inconsistently correlated with fracture risk, and a dose-response meta-analysis for specific outcomes is lacking. The objective of this study was to quantitatively integrate the data on the relationship between alcohol consumption and fracture risk. Pertinent articles were identified in PubMed, Web of Science, and Embase databases up to 20 February 2022. Combined RRs and 95% CIs were estimated by random- or fixed-effects models. Restricted cubic splines were used to model linear or nonlinear relationships. Forty-four articles covering 6,069,770 participants and 205,284 cases of fracture were included. The combined RRs and 95% CIs for highest compared with lowest alcohol consumption were 1.26 (1.17-1.37), 1.24 (1.13-1.35), and 1.20 (1.03-1.40) for total, osteoporotic, and hip fractures, respectively. A linear positive relationship between alcohol consumption and total fracture risk was detected (Pnonlinearity = 0.057); the risk was correlated with a 6% increase (RR, 1.06; 95% CI: 1.02, 1.10) per 14 g/d increment of alcohol consumption. J-shaped relationships of alcohol consumption with risk of osteoporotic fractures (Pnonlinearity < 0.001) and hip fractures (Pnonlinearity < 0.001) were found. Alcohol consumption of 0 to 22 g/d was linked to a reduced risk of osteoporotic fractures and hip fractures. Our findings show that any level of alcohol consumption is a risk factor for total fractures. Moreover, this dose-response meta-analysis shows that an alcohol consumption level of 0 to 22 g/d is related to a reduction in the risk of osteoporotic and hip fractures. The protocol was registered in the International Prospective Register of Systematic Reviews (CRD42022320623).